BioAtla Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Revenue	0	0	0	0.25	0.43	5.2	Upgrade
Revenue Growth (YoY)	-	-	-	-41.72%	-91.75%	-51.07%	Upgrade
Gross Profit	0	0	0	0.25	0.43	5.2	Upgrade
Selling, General & Admin	24.33	25.96	28.79	38.42	10.6	7.55	Upgrade
Research & Development	100.89	103.73	79.35	58.27	19.93	25.92	Upgrade
Operating Expenses	125.21	129.69	108.14	96.69	30.53	33.47	Upgrade
Operating Income	-125.21	-129.69	-108.14	-96.44	-30.1	-28.27	Upgrade
Interest Expense / Income	0	0	0	0	1.39	1.63	Upgrade
Other Expense / Income	-5.98	-6.23	-1.66	-1.04	4.37	-0.1	Upgrade
Pretax Income	-119.24	-123.46	-106.48	-95.4	-35.85	-29.79	Upgrade
Net Income	-119.24	-123.46	-106.48	-95.4	-35.85	-29.79	Upgrade
Shares Outstanding (Basic)	48	48	39	35	8	55	Upgrade
Shares Outstanding (Diluted)	48	48	39	35	8	55	Upgrade
Shares Change	1.07%	22.74%	12.63%	310.07%	-84.56%	-	Upgrade
EPS (Basic)	-2.49	-2.58	-2.74	-2.76	-3.19	-0.53	Upgrade
EPS (Diluted)	-2.49	-2.58	-2.74	-2.76	-3.19	-0.53	Upgrade
Free Cash Flow	-112.24	-104.11	-90.69	-63.14	-36.92	-11.15	Upgrade
Free Cash Flow Per Share	-2.33	-2.18	-2.33	-1.83	-4.38	-0.20	Upgrade
Gross Margin	-	-	-	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-	-	-	-38576.00%	-7016.08%	-543.62%	Upgrade
Profit Margin	-	-	-	-38160.80%	-8357.34%	-572.96%	Upgrade
Free Cash Flow Margin	-	-	-	-25255.20%	-8606.99%	-214.50%	Upgrade
EBITDA	-118.07	-122.24	-105.28	-94.07	-33.46	-27.3	Upgrade
EBITDA Margin	-	-	-	-37627.60%	-7798.60%	-525.08%	Upgrade
Depreciation & Amortization	1.17	1.22	1.2	1.33	1.01	0.86	Upgrade
EBIT	-119.24	-123.46	-106.48	-95.4	-34.46	-28.16	Upgrade
EBIT Margin	-	-	-	-38159.60%	-8033.57%	-541.62%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).